India Emerges as an Important Destination for Global Pharmaceutical Companies

DUBLIN, Ireland--(Business Wire)--
Research and Markets
(http://www.researchandmarkets.com/reports/c90183) has announced the
addition of India: Pharmaceutical to their offering.

In 2006, India ranked 12th in the global pharmaceutical market in
dollar terms with a market share of 1.27% globally. It was estimated
that India's pharmaceutical industry was worth USD 8.8 billion in
2005. Indian companies continue to dominate the generic market with a
total market share of 70% in 2006. Meanwhile, India's pharmaceutical
industry accounted for approximately 21% of the global DMFs. India has
75 US FDA approved plants, the highest number of US FDA approved
plants outside US.

Apart from the relatively low development cost and skilled
manpower, the availability of raw materials at competitive prices
makes India a preferred manufacturing hub for pharmaceutical giants.
Another obvious reason is its IT prowess. As pharmacy research
becoming more and more IT oriented, India is in a position to leverage
on its strong IT base. India is also emerging as an important
destination for global pharmaceutical companies, which are
increasingly considering outsourcing and off shoring their drug
discovery, research and development, and clinical research.

Contents:

1. Industry Profile

1.1 Sector Overview

1.2 Sector Size and Value

1.2.1 Generic Market

1.2.2 Drug Master File (DMF) Filings

1.2.3 US FDA Approved Manufacturing Plants

1.3 Sector Performance

1.3.1 Pharmaceutical Production

1.3.2 Pharmaceutical Export

2. Market Trends and Outlook

2.1 New Patent Law

2.2 Regulatory Changes

2.3 R&D Spending

2.4 Exploiting Generic Opportunities

2.5 Contract Research and Manufacturing (CRAM)

3. Leading Players and Comparative Matrix

3.1 Leading Players

3.1.1 Dr. Reddy's Laboratories

3.1.2 Ranbaxy Laboratories

3.1.3 Cipla

3.1.4 Sun Pharmaceutical

3.1.5 Wockhardt

3.2 Comparative Matrix

3.3 SWOT Analysis

Companies Mentioned:

- Dr. Reddy's Laboratories

- Ranbaxy Laboratories

- Cipla

- Sun Pharmaceutical

- Wockhardt

For more information visit
here

Research and Markets
Laura Wood
Senior Manager
Fax: +353 1 4100 980
press@researchandmarkets.com

Copyright Business Wire 2008